InsidersTradesSigma
엑셀세라퓨틱스 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 엑셀세라퓨틱스 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 엑셀세라퓨틱스 has logged 18 insider filings. Market capitalisation: €18.7bn. The latest transaction was disclosed on 1 April 2026 (Purchase). Among the most active insiders: 이의일. All data is accessible without an account.
18
Insider Decl.
n/a
Thresholds
€17,495
10 ops.
Buy Volume
n/a
4 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 April 2026
Declarations18 total
18 of 18 declarations
About 엑셀세라퓨틱스
Excel Therapeutics is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative therapies.